Polar Capital’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $40.1M | Buy |
|
|||||
|
2020
Q2 | $29.7M | Sell |
|
|||||
|
2020
Q1 | $31.1M | Sell |
|
|||||
|
2019
Q4 | $47.1M | Buy |
|
|||||
|
2019
Q3 | $31.8M | Sell |
|
|||||
|
2019
Q2 | $88.9M | Buy |
|
|||||
|
2019
Q1 | $62.1M | Buy |
|
|||||
|
2018
Q4 | $40.5M | Buy |
|
|||||
|
2018
Q3 | $55.7M | Buy |
|
|||||
|
2018
Q2 | $26.7K | Buy |
|
|||||
|
2018
Q1 | $13.9M | Sell |
|
|||||
|
2017
Q4 | $67.7M | Buy |
|
|||||
|
2017
Q3 | $74.8M | Buy |
|
|||||
|
2017
Q2 | $20M | Sell |
|
|||||
|
2017
Q1 | $53.1M | Sell |
|
|||||
|
2016
Q4 | $56.4M | Buy |
|
|||||
|
2016
Q3 | $2.6M | Buy |
|
|||||
|
2016
Q2 | $1.11M | Sell |
|
|||||
|
2016
Q1 | $3.52M | Sell |
|
|||||
|
2015
Q4 | $35.8M | Buy |
|
|||||
|
2015
Q3 | $28.3M | Sell |
|
|||||
|
2015
Q2 | $32.8M | Buy |
|
|||||
|
2015
Q1 | $1.92M | Buy |
|
|||||
|
2014
Q4 | $997K | Sell |
|
|||||
|
2014
Q3 | $15.6M | Sell |
|
|||||
|
2014
Q2 | $16.8M | Buy |
|